- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 475/00 - Heterocyclic compounds containing pteridine ring systems
Patent holdings for IPC class C07D 475/00
Total number of patents in this class: 186
10-year publication summary
|
13
|
9
|
15
|
12
|
12
|
13
|
8
|
12
|
14
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4650 |
17 |
| Vertex Pharmaceuticals Incorporated | 1597 |
9 |
| Amgen Inc. | 4074 |
8 |
| Blueprint Medicines Corporation | 233 |
8 |
| East China University of Science and Technology | 513 |
7 |
| Vigil Neuroscience, Inc. | 45 |
5 |
| Astex Therapeutics Limited | 237 |
4 |
| Chroma Therapeutics Ltd. | 36 |
4 |
| Dana-Farber Cancer Institute, Inc. | 2571 |
4 |
| Gilead Sciences, Inc. | 2036 |
4 |
| Janus Biotherapeutics, Inc. | 10 |
4 |
| Abbisko Therapeutics Co., Ltd. | 109 |
4 |
| AstraZeneca AB | 2909 |
3 |
| AstraZeneca UK Limited | 642 |
3 |
| Pfizer Inc. | 3387 |
3 |
| CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | 188 |
3 |
| Genentech, Inc. | 3976 |
2 |
| University of Florida Research Foundation, Inc. | 4020 |
2 |
| Purdue Research Foundation | 3612 |
2 |
| Aminopterin LLC | 5 |
2 |
| Other owners | 88 |